- ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Clarithromycin tablets 500 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Clarithromycin 500 mg coated tablets Manufactured by: Sanofi Medley Pharmaceuticals Ltd. Brazilian Industry, in healthy adult, human subjects under fasting condition.
This study compares two different 500mg clarithromycin medicines in healthy adults to ensure they work the same way. Clarithromycin treats infections. It's a single-dose study where each participant tries both medicines at different times to see how the body handles them.
Romania - authorisedTherapeutic use (Phase IV)
Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile neutropenic Oncohaematological Paediatric patients (e-STOP 2)
This study looks into safely stopping antibiotics early for children with cancer who get fevers due to low white blood cells. It compares two groups to see if ending antibiotic treatment sooner is just as safe as longer treatment for these children.
Spain